WS
IBB icon

Wedbush Securities’s iShares Biotechnology ETF IBB Stock Holding History

Wedbush Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Buy
4,126
+131
+3% +$22.4K 0.02% 579
2025
Q4 		$674K Buy
3,995
+1,799
+82% +$292K 0.02% 579
2025
Q3 		$317K Sell
2,196
-131
-6% -$17.9K 0.01% 823
2025
Q2 		$294K Sell
2,327
-884
-28% -$109K 0.01% 847
2025
Q1 		$411K Sell
3,211
-819
-20% -$111K 0.02% 677
2024
Q4 		$533K Sell
4,030
-401
-9% -$56.4K 0.02% 585
2024
Q3 		$645K Sell
4,431
-688
-13% -$99.5K 0.02% 509
2024
Q2 		$703K Sell
5,119
-2,635
-34% -$352K 0.03% 483
2024
Q1 		$1.06M Sell
7,754
-203
-3% -$27.7K 0.04% 365
2023
Q4 		$1.08M Buy
7,957
+461
+6% +$56.2K 0.05% 312
2023
Q3 		$917K Sell
7,496
-588
-7% -$74.8K 0.05% 333
2023
Q2 		$1.03M Buy
8,084
+34
+0.4% +$4.42K 0.05% 320
2023
Q1 		$1.04M Sell
8,050
-22
-0.3% -$2.88K 0.05% 306
2022
Q4 		$1.06M Sell
8,072
-873
-10% -$113K 0.06% 289
2022
Q3 		$1.05M Sell
8,945
-172
-2% -$21.4K 0.06% 269
2022
Q2 		$1.07M Sell
9,117
-6,228
-41% -$739K 0.06% 276
2022
Q1 		$2M Sell
15,345
-841
-5% -$110K 0.09% 181
2021
Q4 		$2.47M Buy
16,186
+218
+1% +$33.8K 0.11% 152
2021
Q3 		$2.58M Sell
15,968
-296
-2% -$49.8K 0.12% 132
2021
Q2 		$2.66M Buy
16,264
+1,143
+8% +$176K 0.13% 130
2021
Q1 		$2.28M Buy
15,121
+5,218
+53% +$829K 0.13% 136
2020
Q4 		$1.5M Buy
9,903
+360
+4% +$51.4K 0.13% 162
2020
Q3 		$1.29M Buy
9,543
+4,149
+77% +$563K 0.12% 176
2020
Q2 		$737K Buy
5,394
+2,672
+98% +$341K 0.07% 296
2020
Q1 		$293K Sell
2,722
-74
-3% -$8.52K 0.03% 531
2019
Q4 		$337K Sell
2,796
-456
-14% -$50.9K 0.03% 625
2019
Q3 		$324K Hold
3,252
– – 0.03% 607
2019
Q2 		$355K Buy
3,252
+7
+0.2% +$745 0.04% 565
2019
Q1 		$363K Sell
3,245
-245
-7% -$26.9K 0.04% 530
2018
Q4 		$337K Sell
3,490
-57
-2% -$6.05K 0.04% 494
2018
Q3 		$433K Buy
3,547
+745
+27% +$87.7K 0.05% 452
2018
Q2 		$308K Sell
2,802
-147
-5% -$15.7K 0.04% 544
2018
Q1 		$315K Buy
2,949
+270
+10% +$29.9K 0.04% 510
2017
Q4 		$286K Buy
2,679
+33
+1% +$3.53K 0.03% 569
2017
Q3 		$294K Buy
2,646
+15
+0.6% +$1.6K 0.04% 561
2017
Q2 		$272K Buy
2,631
+39
+2% +$3.84K 0.04% 580
2017
Q1 		$253K Sell
2,592
-1,341
-34% -$128K 0.03% 601
2016
Q4 		$348K Buy
3,933
+108
+3% +$9.83K 0.05% 446
2016
Q3 		$369K Buy
3,825
+165
+5% +$15.7K 0.06% 432
2016
Q2 		$314K Buy
3,660
+786
+27% +$70.5K 0.05% 438
2016
Q1 		$250K Sell
2,874
-1,260
-30% -$113K 0.04% 505
2015
Q4 		$466K Buy
4,134
+900
+28% +$97.7K 0.08% 265
2015
Q3 		$327K Sell
3,234
-3,279
-50% -$393K 0.07% 344
2015
Q2 		$801K Buy
6,513
+429
+7% +$51.4K 0.15% 164
2015
Q1 		$697K Buy
6,084
+1,113
+22% +$123K 0.12% 195
2014
Q4 		$503K Sell
4,971
-987
-17% -$95.9K 0.08% 267
2014
Q3 		$544K Sell
5,958
-135
-2% -$11.8K 0.08% 243
2014
Q2 		$522K Buy
6,093
+210
+4% +$16.5K 0.08% 254
2014
Q1 		$464K Buy
5,883
+465
+9% +$38.7K 0.08% 252
2013
Q4 		$410K Buy
5,418
+1,455
+37% +$103K 0.1% 246
2013
Q3 		$277K Buy
+3,963
New +$260K 0.07% 324

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wedbush Securities's IBB Position: Q1 2026 in Review

Wedbush Securities increased its iShares Biotechnology ETF (IBB) stake by 3.3% in Q1 2026, buying an estimated $22.4K and bringing the position to 4,126 shares worth $697K. The position accounts for 0.02% of the portfolio, ranked #579.

Wedbush Securities first reported a position in IBB in Q3 2013 and has held it in 51 quarters since. The position peaked at $2.66M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Wedbush Securities held 4,126 shares of iShares Biotechnology ETF worth $697K as of Q1 2026.
  • Wedbush Securities bought 131 iShares Biotechnology ETF shares in Q1 2026, an estimated $22.4K.
  • iShares Biotechnology ETF made up 0.02% of Wedbush Securities's portfolio in Q1 2026, its #579 holding.
  • Wedbush Securities first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 51 quarters since.
  • Wedbush Securities's iShares Biotechnology ETF position peaked at $2.66M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.